Annual edition
Subsec. (c). Pub. L. 103–43 struck out subsec. (c) which directed Biomedical Ethics Advisory Committee to conduct a study of the nature, advisability, and biomedical and ethical implications of exercising any waiver of the risk standard published in section 46.102(g) of part 46 of title 45 of the Code of Federal Regulations and to report its finding to the Biomedical Ethics Board not later than 24 months after Nov. 4, 1988, which report was to be then transmitted to specified Congressional committees.
Source credit
Pub. L. 103–43, title I, § 121(b)(1), June 10, 1993, 107 Stat. 133.
Nov 4, 1988 – Jun 10, 1993
Amended · full text not held
Subsec. (c)(1). Pub. L. 100–607, § 157(b), substituted “24 months after November 4, 1988” for “thirty months after November 20, 1985”.
Source credit
amended Pub. L. 100–607, title I, §§ 156, 157(b), Nov. 4, 1988, 102 Stat. 3059
Nov 20, 1985 – Nov 4, 1988
Amended · full text not held
Source credit
July 1, 1944, ch. 373, title IV, § 498, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 877
Jul 1, 1944 – Nov 20, 1985
Enacted · full text not held
Source credit
July 1, 1944, ch. 373, title IV, § 498, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 877
